Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP; Neil M. Iyengar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
- Sarah H. Donahue, MPH, NP
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CE
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD
0.25 credits
- Joseph Kim, MD, MPH, MBA, FACHE
- Samir Dalia, MD
- Christopher Jurief
0.25 credits
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
CME/CE
Decision in Context: A Practical Framework for Sequencing Systemic and CNS Therapies in Brain Metastases
Barbara O'Brien, MD
0.25 credits
- Barbara O'Brien, MD
0.25 credits
Brain Metastases Management: From Detection to Multidisciplinary Care
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®
Brain Metastases Management: From Detection to Multidisciplinary Care
Barbara O'Brien, MD
1.00 program credit
- Barbara O'Brien, MD
1.00 program credit
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
MinuteCE®
HER2+ Breast Cancer With Brain Metastases: Rethinking First-Line Treatment in the ADC Era
Barbara O'Brien, MD; Nadia Harbeck, MD, PhD
1.00 program credit
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credit
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
Barbara O'Brien, MD; Nadia Harbeck, MD, PhD
1.00 program credit
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credit
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD; Melin Khandekar, MD, PhD
1.00 program credit
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credit
Managing Brain Metastases Through Multidisciplinary Team Collaboration
Managing Brain Metastases Through Multidisciplinary Team Collaboration
MinuteCE®
Managing Brain Metastases Through Multidisciplinary Team Collaboration
Benjamin Levy, MD
1.00 program credit
- Benjamin Levy, MD
1.00 program credit

Medical News

Medical News
AI-Assisted Colorectal Lesion Detection Falls Short In Private Practice Trial
05/12/2026
Read more
Medical News
Metal Stent Drainage vs Early Surgery in Pancreatic Cancer
05/12/2026
Read more
Medical News
Extended Endocrine Therapy and Breast Cancer Subtype
05/11/2026
Read more
Medical News
Pembrolizumab Plus Weekly Paclitaxel in Keynote-B96 Recurrent Ovarian Cancer
05/11/2026
Read more

CME/CE

Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Enriqueta Felip, MD; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Enriqueta Felip, MD
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CE
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
0.25 credits
- Cem Akin, MD, PhD
0.25 credits
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Benjamin Levy, MD
0.25 credits
- Benjamin Levy, MD
0.25 credits
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
CME/CE
Progress in Breast Cancer Care: Translating SABCS Data Into Practice
Charles E. Geyer Jr., MD, FACP; Komal Jhaveri, MD, FACP
0.25 credits
- Charles E. Geyer Jr., MD, FACP
- Komal Jhaveri, MD, FACP
0.25 credits

Clinical Practice

Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Brian P. McDonough, MD, FAAFP; Bilal Siddiqui, MD
- Brian P. McDonough, MD, FAAFP
- Bilal Siddiqui, MD
Epic Aura for CRC Screening: A Real-World Perspective
Epic Aura for CRC Screening: A Real-World Perspective
Clinician's Roundtable
Epic Aura for CRC Screening: A Real-World Perspective
Natalia Usoltseva MD, FACP, MHA
- Natalia Usoltseva MD, FACP, MHA
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
Benjamin Levy, MD; Melin Khandekar, MD, PhD
1.00 program credit
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credit
MinuteCE®
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
Barbara O'Brien, MD; Benjamin Levy, MD
1.00 credit 6 episodes
- Barbara O'Brien, MD
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
- Nadia Harbeck, MD, PhD
1.00 credit 6 episodes

Programs

Improving CRC Screening Workflows: A PCP's Recommendations
Improving CRC Screening Workflows: A PCP's Recommendations
Clinician's Roundtable
Improving CRC Screening Workflows: A PCP's Recommendations
Natalia Usoltseva MD, FACP, MHA
- Natalia Usoltseva MD, FACP, MHA
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP; Madison Conces, MD
- Brian P. McDonough, MD, FAAFP
- Madison Conces, MD
- Midhun Malla, MD
Making Mechanism-Based Treatment Decisions in cGVHD
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®
Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP; Alicia Lieberman, MD, MS
- Brian P. McDonough, MD, FAAFP
- Alicia Lieberman, MD, MS
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
- Raghava Reddy Induru, MD